On April 10, 2026, three directors of Sensei Biotherapeutics, Inc. submitted conditional resignations effective after the Annual Meeting slated for June 10, 2026, depending on stockholder approval of significant proposals, including a major stock issuance and charter amendment. Their resignations were not due to any disagreements with the company's operations.